Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core. Read more about Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.
Cores for geriatric oncology infrastructure in the Cancer and Aging Research Group: Biostatistics, epidemiology, and research design (the analytics core). Read more about Cores for geriatric oncology infrastructure in the Cancer and Aging Research Group: Biostatistics, epidemiology, and research design (the analytics core).
Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group. Read more about Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group.
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology. Read more about Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.
Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD. Read more about Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD.
From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults. Read more about From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults.
A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging. Read more about A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging.
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance). Read more about Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).
Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults. Read more about Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
Chemotherapy-related cognitive impairment in older patients with cancer. Read more about Chemotherapy-related cognitive impairment in older patients with cancer.
